Form 4: McKesson Director Lynne Doughtie Receives Annual RSU Grant

McKesson Corporation Director Lynne M. Doughtie was granted 301 Restricted Stock Units (RSUs) under the company's 2022 Stock Plan, vesting immediately with share receipt deferred until board departure.

Summary

• Lynne M. Doughtie, a Director of McKesson Corp (MCK), received an annual grant of 301 Restricted Stock Units (RSUs).
• The grant was made on July 30, 2025, under the 2022 Stock Plan.
• These RSUs vest immediately, but the underlying 301 shares of common stock will not be received until Ms. Doughtie departs from the Board.
• The transaction price for the RSUs was $0.
• Following this transaction, Ms. Doughtie beneficially owns 301 RSUs directly.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is a positive for aligning interests but does not indicate significant new positive or negative developments for the company itself beyond standard compensation practices.

Positives

• Grant of 301 Restricted Stock Units (RSUs) to a Director aligns her interests with shareholders.
• Immediate vesting of the RSUs indicates confidence and provides immediate equity ownership, albeit deferred.
• The grant is part of an annual program under the 2022 Stock Plan, suggesting a structured compensation approach for directors.

Negatives

• No immediate cash flow or liquidity for the director as share receipt is deferred until departure from the Board.

Future Outlook

The filing indicates future receipt of shares upon the director's departure from the board, but no broader forward-looking statements about the company's performance or strategy.

Industry Context

This is a standard insider transaction filing (Form 4) for director compensation. It reflects common practices in large healthcare distribution companies like McKesson, where equity grants are used to align director interests with long-term shareholder value.

Comparison to Industry Standards

• Granting Restricted Stock Units (RSUs) as part of director compensation is a common practice across large-cap companies, including peers in the healthcare distribution sector such as Cardinal Health (CAH) and AmerisourceBergen (ABC).
• The deferral of share receipt until board departure is a typical corporate governance mechanism designed to encourage long-term commitment and align interests over an extended period, consistent with best practices for independent director compensation.
• The use of a formal stock plan (2022 Stock Plan) for such grants is standard for publicly traded companies to ensure compliance and transparency in equity compensation.

Corporate Governance

Related Party Transactions

• Grant of 301 Restricted Stock Units (RSUs) to Lynne M. Doughtie, a Director of McKesson Corp, as part of her annual compensation.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns her interests with shareholders, potentially encouraging long-term value creation.

Next Steps

• Lynne M. Doughtie will receive the underlying 301 shares of common stock upon her departure from the McKesson Board.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director and does not contain information that would fundamentally alter the investment thesis for McKesson Corp. It reflects standard corporate governance practices for aligning director interests with long-term shareholder value. Therefore, it does not warrant a change in an existing investment position.

Keywords

McKesson, MCK, Restricted Stock Units, RSU, Director Compensation, Stock Plan, Corporate Governance, Insider Transaction, Form 4